Insurance Coverage
Genetic Testing
Exome
Genome

Does insurance cover genetic testing? Costs, coverage and what to expect

Health insurance may cover clinically indicated genetic testing, but coverage and out-of-pocket costs vary by plan, test and individual situation. Learn what can affect coverage, what you may pay, and how GeneDx can help you understand financial and access options.

Blog
Education

Key takeaways:

  • Health insurance may cover clinically indicated genetic testing, but coverage depends on the patient’s plan, the test ordered, the clinical situation and payer requirements.
  • Out-of-pocket costs vary by individual plan and benefits. In recent GeneDx billing data, 90% of insured patients had an out-of-pocket cost between $0 and $100 after insurance for outpatient exome or genome testing.*
  • Exome and genome sequencing may be covered when clinical and plan requirements are met, but coverage and prior-authorization requirements vary.
  • GeneDx offers financial and access support, including cost estimate support, financial assistance and Accelerating Answers Programs for eligible patients.

Does insurance cover genetic testing?

Health insurance may cover clinically indicated genetic testing when the test and the patient’s situation meet the health plan’s coverage requirements. Coverage is not the same for every patient: it can vary by insurance plan, the type of genetic test ordered, the clinical reason for testing, network status and payer requirements.

90%

of patients had an out-of-pocket cost between $0-$100 after insurance for outpatient exome or genome testing.1,2

Even when a test is covered, a patient may still have an out-of-pocket cost. Deductibles, copays, coinsurance and other plan details can affect what a patient may owe. That is why it is important to understand both whether a test is covered and what the patient’s specific benefits may mean for cost.

What determines whether genetic testing is covered?

There is no single insurance rule for all genetic testing. Coverage can depend on several factors, and requirements may differ from one health plan to another.

Clinical indication and the test ordered

Health plans may consider why testing is being ordered, the patient’s symptoms and medical history, previous testing, and the specific genetic test requested. Requirements can differ for a targeted test, multigene panel, exome sequencing, genome sequencing or another type of clinically indicated testing.

Prior authorization and supporting information

Some health plans require prior authorization before genetic testing. The plan may also request clinical information that supports why the test is appropriate. Depending on the test and plan, the ordering healthcare provider and laboratory may be involved in this process.

Health plan and network considerations

Two people with insurance from the same company may have different benefits because coverage is determined by the specific health plan. Network status may also affect coverage or patient responsibility. Patients should confirm the requirements and benefits that apply to their individual plan rather than relying on the insurer name alone.

How much does genetic testing cost with insurance?

There is not one standard out-of-pocket price for genetic testing with insurance. What a patient may owe can depend on the test ordered, whether the test is covered, the patient’s benefits, network status and any prior-authorization requirements.

Deductible, copay and coinsurance

A deductible is the amount a patient generally pays for covered healthcare services before the health plan begins paying according to the plan’s terms. A copay is typically a fixed amount for a covered service, while coinsurance is generally a percentage of the allowed cost. Depending on the plan, one or more of these may affect the amount a patient owes for genetic testing. Learn more about why year-end may be a good time to order genetic testing.

Cost estimates are not final bills

A cost estimate can help an insured patient understand what they may expect to pay out of pocket, but an estimate is not a guarantee of the final amount. GeneDx offers a cost estimate tool in the provider portal during the order process; the patient’s insurance determines the final bill.

Are exome and genome sequencing covered by insurance?

Exome and genome sequencing may be covered by insurance when clinical and plan requirements are met, but coverage varies. The patient’s clinical indication, the test ordered, plan criteria, network status and prior-authorization requirements may all affect coverage.

If a healthcare provider recommends exome or genome sequencing, ask what the patient’s health plan requires and whether prior authorization is needed. Search interest in the cost of whole exome and whole genome sequencing is high, but a generic list price does not tell an insured patient what they will actually owe. For that reason, coverage and individual benefits are important parts of the cost conversation.

How can I find out whether my insurance covers genetic testing?

Start with the specific test your healthcare provider is recommending. Then confirm the requirements that apply to your individual health plan. Useful questions include:

  • Is this specific genetic test covered under my plan?
  • Does the plan require prior authorization?
  • Does network status affect coverage or what I may owe?
  • What deductible, copay or coinsurance may apply?
  • What clinical documentation does the plan require?
  • Can I receive a cost estimate before testing begins?

If GeneDx testing is being ordered, the ordering provider can also review GeneDx financial and access resources during the order process.

What is prior authorization for genetic testing?

Prior authorization is a process some health plans use to review whether a service meets their coverage requirements before it is performed. For genetic testing, a plan may request information about the patient’s clinical presentation, medical history, previous testing and the test being ordered.

Prior authorization does not guarantee that a claim will be paid or that a patient will have no out-of-pocket cost. Coverage and final patient responsibility remain subject to the health plan’s terms and claim determination. Learn more about prior authorization support for health care providers.

What if insurance does not cover genetic testing?

An insurance denial does not necessarily mean there are no other ways to access testing. Depending on the test and patient eligibility, financial assistance or a GeneDx genetic testing access program may help reduce cost barriers. Patients and providers can review current GeneDx financial and access support to understand available options.

What if I do not have insurance?

Patients without insurance may still have access options depending on the test and eligibility. GeneDx offers a Financial Assistance Program, and some patients may qualify for an Accelerating Answers Program that reduces or eliminates testing costs for specific conditions or clinical indications. Availability and eligibility vary by program.

How GeneDx helps with financial and access support

GeneDx offers tools and programs designed to help reduce out-of-pocket costs and improve access to genetic testing. Available support depends on the patient’s insurance, test and eligibility.

Cost estimate support

For insured patients, GeneDx offers a cost estimate tool within the provider portal during the order process. The estimate can help patients understand what they may expect to pay out of pocket, but it is an estimate only; the patient’s insurance determines the final bill.

Financial Assistance Program

The GeneDx Financial Assistance Program is designed to help reduce potential out-of-pocket costs associated with testing for eligible patients.

Accelerating Answers Programs

Accelerating Answers Programs are GeneDx’s portfolio of genetic testing access programs designed to help reduce or eliminate cost barriers for eligible patients. Through sponsored testing and partnership programs, providers can find options that support access to exome, genome and other genetic testing across a range of conditions and clinical indications.

Why coverage for appropriate genetic testing matters

For patients with an appropriate clinical indication, genetic testing can help identify an underlying diagnosis and provide information that may guide care. Earlier genomic answers may also help reduce parts of the diagnostic odyssey, such as repeated or unnecessary testing, for some patients. This article is intended to help patients and families understand coverage and access; health plans and health systems looking for evidence on healthcare utilization, costs and outcomes should be directed to GeneDx’s dedicated evidence resources.

What to ask before genetic testing

Before testing begins, consider asking your healthcare provider, health plan or GeneDx support team:

  • What genetic test is being recommended, and why?
  • Is the test covered under my specific health plan?
  • Does my plan require prior authorization?
  • Does network status affect my coverage or potential cost?
  • Can I receive a cost estimate before testing?
  • What financial assistance or access programs may be available if cost is a concern?

‍

Not sure what genetic testing may cost or what options are available?

Learn about GeneDx cost estimate support, financial assistance and genetic testing access programs.

Related articles

Financial
Genomics
Why year-end can be a good time to order genetic testing

As year-end approaches, some patients may have met more of their annual insurance deductible, potentially reducing out-of-pocket costs for covered genetic testing. Consider which patients may benefit from another conversation about exome or genome sequencing before benefits reset.

Epilepsy
Why ordering exome sequencing first matters for epilepsy diagnosis

For patients with unexplained seizures, ordering exome sequencing first can provide answers faster than starting with multi-gene panels or chromosomal microarray.

Clinical Research
HEOR
Real-world evidence
Exome
The next step in modernizing Medicaid coverage for exome and genome sequencing

New research presented at the Medicaid Health Plans of America Annual Conference found that, among children with developmental delay, intellectual disability, and epilepsy who underwent stepwise genetic testing, prior testing added an average of 19 months and $2,039 in genetic testing costs before exome or genome sequencing (ES/GS).

‍

In a budget impact analysis of 5,821 children covered by Medicaid, a first-tier ES/GS approach was associated with an estimated $294 in savings per patient per year over five years. Some Medicaid plans have already updated their coverage policies in response to evidence and professional society guidance. These findings support continued modernization among the remaining plans that still require prior testing, with the potential to reduce unnecessary testing, shorten time to diagnosis, and improve long-term budget performance.

Science that serves people

We’re scientists, but we’re also parents, siblings, and caregivers who understand how powerful an answer can be.